Twist Bioscience Executives Make Significant Stock Trades.

Twist Bioscience Corp (TWST) has recently disclosed several transactions involving its executives. Specifically, President and Chief Operating Officer Finn Patrick John acquired 3,279 shares at a price of $8.82 per share on January 13, 2026. In contrast, he subsequently sold 23,279 shares at a price of $40 per share on the same day. Additionally, Chief Financial Officer Adam Laponis sold 3,000 shares at a price of $40 per share on January 13, 2026. These transactions reflect the executives' confidence in the company's future prospects and demonstrate their commitment to growing the business.